share_log

iBio Inc | 4: Statement of changes in beneficial ownership of securities-Director Schimmelpennink Evert B.

iBio Inc | 4: Statement of changes in beneficial ownership of securities-Director Schimmelpennink Evert B.

iBio Inc | 4:持股變動聲明-董事 Schimmelpennink Evert B.
美股SEC公告 ·  11/25 13:38

Moomoo AI 已提取核心訊息

Evert B. Schimmelpennink, associated with iBio Inc, reported a transaction dated 11/21/2024. However, the details of the transaction, including the number of shares and transaction type, are not provided in the announcement.The announcement lacks specific information on the nature of the securities involved, such as whether they are non-derivative or derivative securities. Additionally, the relationship of Schimmelpennink to iBio Inc is not specified, leaving the context of the transaction unclear.Investors should note that the information provided is incomplete, and further details may be necessary to fully understand the implications of this transaction for iBio Inc.
Evert B. Schimmelpennink, associated with iBio Inc, reported a transaction dated 11/21/2024. However, the details of the transaction, including the number of shares and transaction type, are not provided in the announcement.The announcement lacks specific information on the nature of the securities involved, such as whether they are non-derivative or derivative securities. Additionally, the relationship of Schimmelpennink to iBio Inc is not specified, leaving the context of the transaction unclear.Investors should note that the information provided is incomplete, and further details may be necessary to fully understand the implications of this transaction for iBio Inc.
Evert b. Schimmelpennink,與ibio inc有關,報告了一項截至2024年11月21日的交易。然而,交易的詳細信息,包括股票數量和交易類型,在公告中未提供。 該公告缺乏有關涉及的證券性質的具體信息,例如它們是非衍生或衍生證券。此外,Schimmelpennink與ibio inc的關係未指明,使得交易的背景不清楚。 投資者應該注意到所提供的信息不完整,可能需要進一步的細節才能充分理解此交易對ibio inc的影響。
Evert b. Schimmelpennink,與ibio inc有關,報告了一項截至2024年11月21日的交易。然而,交易的詳細信息,包括股票數量和交易類型,在公告中未提供。 該公告缺乏有關涉及的證券性質的具體信息,例如它們是非衍生或衍生證券。此外,Schimmelpennink與ibio inc的關係未指明,使得交易的背景不清楚。 投資者應該注意到所提供的信息不完整,可能需要進一步的細節才能充分理解此交易對ibio inc的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息